全文获取类型
收费全文 | 311篇 |
免费 | 24篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 8篇 |
妇产科学 | 11篇 |
基础医学 | 47篇 |
口腔科学 | 6篇 |
临床医学 | 35篇 |
内科学 | 55篇 |
皮肤病学 | 22篇 |
神经病学 | 28篇 |
特种医学 | 8篇 |
外科学 | 20篇 |
综合类 | 3篇 |
预防医学 | 43篇 |
眼科学 | 3篇 |
药学 | 26篇 |
肿瘤学 | 19篇 |
出版年
2023年 | 3篇 |
2022年 | 8篇 |
2021年 | 15篇 |
2020年 | 9篇 |
2019年 | 14篇 |
2018年 | 9篇 |
2017年 | 14篇 |
2016年 | 7篇 |
2015年 | 14篇 |
2014年 | 18篇 |
2013年 | 14篇 |
2012年 | 29篇 |
2011年 | 31篇 |
2010年 | 11篇 |
2009年 | 12篇 |
2008年 | 19篇 |
2007年 | 13篇 |
2006年 | 8篇 |
2005年 | 19篇 |
2004年 | 17篇 |
2003年 | 14篇 |
2002年 | 15篇 |
2001年 | 1篇 |
2000年 | 2篇 |
1998年 | 1篇 |
1997年 | 1篇 |
1992年 | 2篇 |
1990年 | 3篇 |
1989年 | 2篇 |
1988年 | 1篇 |
1987年 | 2篇 |
1986年 | 1篇 |
1980年 | 1篇 |
1973年 | 1篇 |
1972年 | 1篇 |
1969年 | 1篇 |
1968年 | 2篇 |
1966年 | 1篇 |
排序方式: 共有336条查询结果,搜索用时 15 毫秒
71.
72.
Quantitative real-time polymerase chain reaction (qPCR) has become a widely used tool in the search for disease genes. When examining gene expression with qPCR in psychiatric diseases, endogenous reference gene(s) must be used for normalization. Traditionally, genes such as beta-actin (ActB), Gapd, and 18s rRNA, assumed to be stably expressed, have been used for normalization. However, it has become clear that expression of these genes is influenced by different experimental paradigms. Since stable gene expression of houskeeping genes (HKGs), therefore, cannot be expected, alternative strategies are warranted. With the overall aim to inspect the gene expression of three target genes, NMDAR1, SORT, and CREB, in rat hippocampus, we tested a panel of eight HKGs, 18s rRNA, ActB, CycA, Gapd, Hmbs, Hprt1, Rpl13A, and Ywhaz in order to select the most stably expressed gene, using the NormFinder and geNorm software applets. Additionally, we have applied four different normalization approaches for normalization of the three target genes. We found using the NormFinder software that Ywhaz is the most stably expressed gene among the eight tested HKGs. However, the results of the analysis of the target genes are highly dependent on the choice of normalization approach. Moreover, the number of HKGs, used for selection of the most stable HKG, also influences on the result of the gene expression analysis of target genes. These results underline the importance of choosing a proper normalization strategy when analyzing gene expression with qPCR. The strategy should be unbiased and carried out in every specific experimental setting. 相似文献
73.
Golub JE Saraceni V Cavalcante SC Pacheco AG Moulton LH King BS Efron A Moore RD Chaisson RE Durovni B 《AIDS (London, England)》2007,21(11):1441-1448
BACKGROUND: Tuberculosis is a common complication and leading cause of death in HIV infection. Antiretroviral therapy (ART) lowers the risk of tuberculosis, but may not be sufficient to control HIV-related tuberculosis. Isoniazid preventive therapy (IPT) reduces tuberculosis incidence significantly, but is not widely used. METHODS: We analysed tuberculosis incidence in 11 026 HIV-infected patients receiving medical care at 29 public clinics in Rio de Janeiro, Brazil, between 1 September 2003 and 1 September 2005. Data were collected through a retrospective medical record review. We determined rates of tuberculosis in patients who received neither ART nor IPT, only ART, only IPT, or both ART and IPT. RESULTS: The overall tuberculosis incidence was 2.28 cases/100 person-years (PY) [95% confidence interval (CI) 2.06-2.52]. Among patients who received neither ART nor IPT, incidence was 4.01/100 PY. Patients who received ART had an incidence of 1.90/100 PY (95% CI 1.66-2.17) and those treated with IPT had a rate of 1.27/100 PY (95% CI 0.41-2.95). The incidence among patients who received ART and IPT was 0.80/100 PY (95% CI 0.38-1.47). Multivariate Cox proportional hazards modeling revealed a 76% reduction in tuberculosis risk among patients receiving both ART and IPT (adjusted relative hazard 0.24; P < 0.001) after adjusting for age, previous tuberculosis diagnosis, and CD4 cell counts at baseline. CONCLUSION: The use of both IPT and ART in HIV-infected patients is associated with significantly reduced tuberculosis incidence. In conjunction with expanded access to ART, the wider use of IPT in patients with HIV will improve tuberculosis control in high burden areas. 相似文献
74.
75.
Melano R Corso A Petroni A Centrón D Orman B Pereyra A Moreno N Galas M 《The Journal of antimicrobial chemotherapy》2003,52(1):36-42
Klebsiella pneumoniae M1803, isolated from a paediatric patient with chronic urinary infection, presented nine antimicrobial resistance mechanisms harboured on two conjugative megaplasmids, in addition to the chromosomally mediated SHV-1 beta-lactamase. These nine antimicrobial resistance mechanisms comprised two extended-spectrum beta-lactamases (ESBLs) (PER-2 and CTX-M-2), TEM-1-like, OXA-9-like, AAC(3)-IIa, AAC(6')-Ib, ANT(3")-Ia and resistance determinants to tetracycline and chloramphenicol. During fluoroquinolone treatment, a variant derived from M1803 (named M1826) was selected, with an overall increase of MICs, in particular of cefoxitin and carbapenems. No enzymic activity against these latter drugs was found. Mutations in the region analogous to the quinolone resistance-determining region were not found. Strain M1826 was deficient in OmpK35/36 expression, which produced the decrease in the susceptibility to cefoxitin, carbapenems and fluoroquinolones. The blaCTX-M-2 gene was located in an unusual class 1 integron, which includes Orf513, as occurred in the recently described In35. In addition, Tn3 and Tn1331 were detected in both K. pneumoniae isolates. This is the first report of in vivo selection of an OmpK35/36 deficiency in a K. pneumoniae strain that produced a novel combination of two ESBLs (CTX-M-2 and PER-2) during fluoroquinolone treatment in a paediatric patient with chronic urinary infection. 相似文献
76.
González-Treviño O Yamamoto-Furusho JK Cutiño-Moguel T Hernandez-Martínez B Rodríguez-Reyna TS Ruiz-Morales JA Vargas-Alarcón G Granados J 《Autoimmunity》2002,35(4):265-269
Several studies have been done regarding the genetic susceptibility to autoimmune thyroid disease, particularly those related to the role of Major Histocompatibility Complex (MHC) genes in the etiology of the disease. In the present study, we report class I and class II MHC haplotypes in nine individuals affected by Hashimoto thyroiditis and Graves' disease who belong to two distinct Mexican families. In one of the families, Hashimoto thyroiditis was associated with the Human Leukocyte Antigen (HLA) HLA-DR3 allele whereas in the other family the disease was associated with homozygosity for the HLA-DR4 (DRB1*0407), HLA-DQ3 (DQB1*0302) haplotype. On the other hand, Graves' disease was found to be associated in one of the families with HLA-DR2 (DRB1*1501) and in the other with homozygosity for the HLA-DR7 (DRB*0701) and HLA-DQ2 (DQB1*0201) haplotype. These results confirm that in Mexicans as in other ethnic groups, genes located within the MHC region are related to the genetic susceptibility to develop autoimmune thyroid disease. 相似文献
77.
Fabio Bellina Matteo Biagetti Sara Guariento Marco Lessi Mattia Fausti Paolo Ronchi Elisabetta Rosadoni 《RSC advances》2021,11(41):25504
A variety of 2-alkynyl(benzo)imidazoles have been synthesized by dehydrogenative alkynylation of (benzo)imidazoles with terminal alkyne in NMP under air in the presence of Ag2CO3 as the oxidant and Pd(OAc)2 as the catalyst precursor. The data obtained in this study support a reaction mechanism involving a non-concerted metalation deprotonation (n-CMD) pathway.The regioselective synthesis of 2-alkynyl(benz)imidazoles was successfully achieved by Pd(ii)/Ag(i)-mediated dehydrogenative alkynylation of the corresponding (benz)imidazoles with terminal alkynes in an open vessel.The development of synthetic protocols that enable the direct and selective functionalization of Csp2–H bonds are of primary importance in the decoration of the imidazole scaffold.1–10 The presence of two nitrogen atoms in the pentatomic structure of this important azole in fact introduces a differentiation in the chemical behaviour of the three C–H bonds, allowing their selective involvement in carbon–carbon bond-forming reactions as long as appropriate experimental conditions are identified.During our studies dedicated to the synthesis and investigation of azole-based fluorophores featuring a π-conjugated backbone end-capped with electron-donating (EDG) and electron-acceptor (EWG) groups (the so-called “push–pull” systems),11–15 taking into account the structural characteristics and synthetic versatility of a triple carbon–carbon bond16–23 that make it an excellent π-spacer, we recently decided to evaluate the possibility of obtaining alkynyl-substituted imidazoles by transition metal-catalyzed Csp2–Csp bond-forming reactions. Among the synthetic procedures that allow the selective alkynylation of imidazoles and other five-membered heteroarenes,5,24 there is no doubt that the possibility of forming the new σ carbon–carbon bond through the double activation of two distinct carbon–hydrogen bonds through a cross-dehydrogenative alkynylation (CDA) represents the best synthetic approach in terms of atom economy and functional group tolerance (eqn (1), Scheme 1).25–34 In fact, when compared with the transition metal-catalyzed direct Csp2–H alkynylation protocols involving 1-haloalkynes (the so-called “inverse Sonogashira coupling”) (eqn (2), Scheme 1),35–45 hypervalent iodine reagents (eqn (3), Scheme 1),46–48 or α,β-ynoic acids (decarboxylative direct arylation) (eqn (4), Scheme 1),26,49,50 the CDA methodology makes it possible to use terminal alkynes without the need for preliminary activation.5,24Open in a separate windowScheme 1Synthetic protocols for the transition metal-catalyzed Csp2–H alkynylation of heteroarenes.Despite several papers having been dedicated to the dehydrogenative alkynylation of pyrroles,27 indoles,27,31 oxazoles,27,30,32–34 benzoxazoles,26,29,30,32,34 thiazoles,27,30 benzothiazoles,26,29,31,32,34 pyrazoles,25,27 1,3,4-oxadiazoles,33 imidazopyridines,27,34 and N-substituted sydnones,28 to the best of our knowledge a study specifically devoted to the dehydrogenative alkynylation of imidazoles has never been reported. However, careful reading the literature where alkynylation reactions involving azoles other than imidazole were described, it emerged that two papers reported the C-2 alkynylation of N-benzylimidazole and N-benzylbenzimidazole with phenylacetylene. In a study mainly devoted to the dehydrogenative alkynylation of imidazo[1,5-a]pyridine, Shihabara, Dohke and Murai employed the commercially unavailable Pd(ii) complex bi(4-nitropyridinyl)Pd(OAc)2, Ag2CO3 as the oxidant and AcOH as additive, in a 95 : 5 mixture of DMF and DMSO for 2 h at 120 °C under argon.34 Due to the propensity of alkynes to give Glaser-type homocoupling side-products in the presence of silver(i) salts,51 phenylacetylene was slowly added over 90 min to the reaction mixture. In 2015, Likhar, Kantam and co-workers used a synthetic Pd(ii) carbene complex. In this case Ag2O was used as the oxidant, Cs2CO3 base, performing the coupling in DMF at 85 °C under air.26Encouraged by these results but with the intention of developing a simplified procedure that would allow the use of a commercial Pd(ii) pre-catalyst in the absence of any palladium ligands, we decided to review the conditions of reaction and, in this work, we are pleased to summarize the results obtained in the synthesis of 2-alkynylimidazole derivatives by dehydrogenative alkynylation with terminal alkynes (Scheme 2). In particular, a careful screening allowed us to show how the reactivity of Csp2–H bond of imidazole derivatives and other azoles can be enhanced simply by performing the alkynylation using NMP as the reaction solvent, under air in non-anhydrous conditions, and without the need for palladium ligands.Open in a separate windowScheme 2Pd/Ag-Promoted dehydrogenative alkynylation of imidazole derivatives.We decided to start our synthetic investigations by trying a cross-dehydrogenative coupling between N-methylbenzimidazole (1) and phenylacetylene (2a), chosen as typical coupling partners, under conditions very similar to those proposed by Murai and co-workers for the regioselective C-3 dehydrogenative alkynylation of 1-alkynyl-3-arylimidazo[1,5-a]-pyridines.34Hence, to a mixture of 1.0 mmol 1, 5 mol% Pd(OAc)2, 1.5 equiv. Ag2CO3, and 1.0 equiv. AcOH in a 95 : 5 (v/v) mixture of DMF and DMSO under argon 3.0 equiv. of 2a were added dropwise over 90 min. However, after 2 h at 120 °C a 56% GLC conversion of 1 was recorded, and the required 2-phenylethynyl-N-methylbenzimidazole (3a) was obtained in only 34% GLC yield (entry 1, Entry Pd cat. (mol%) Ag(i) salt (equiv.) RCOOH Solvent Temp./react. timeb (°C/h) 1 GLC conversionc (%) 3a GLC yieldd (%) 3a:4 AP% 1e Pd(OAc)2 (5) Ag2CO3 (1.5) AcOH DMF/DMSO (95 : 5) 120/2 56 34 57 : 43 2 Pd(OAc)2 (5) Ag2CO3 (1.5) AcOH DMF/DMSO (95 : 5) 100/5.5 67 66 32 : 68 3 Pd(OAc)2 (5) Ag2CO3 (2.0) AcOH DMF/DMSO (95 : 5) 100/2 73 70 34 : 66 4 Pd(OAc)2 (5) — AcOH DMF/DMSO (95 : 5) 100/3.5 NR — — 5 Pd2(dba)3 (2.5) Ag2CO3 (2.0) AcOH DMF/DMSO (95 : 5) 100/3.5 73 69 30 : 70 6 Pd(acac)2 (5) Ag2CO3 (2.0) AcOH DMF/DMSO (95 : 5) 100/3.5 67 63 27 : 73 7 PdCl2 (5) Ag2CO3 (2.0) AcOH DMF/DMSO (95 : 5) 100/3.5 72 68 35 : 65 8 Pd(OAc)2 (5) Ag2CO3 (2.0) — DMF/DMSO (95 : 5) 100/3.5 53 23 72 : 28 9 Pd(OAc)2 (5) Ag2CO3 (2.0) — AcOH 100/3.5 0 — 0 : 100 10 Pd(OAc)2 (2.5) Ag2CO3 (2.0) AcOH DMF/DMSO (95 : 5) 100/3.5 76 69 30 : 70 11 Pd(OAc)2 (2.5) AgOAc (2.0) AcOH DMF/DMSO (95 : 5) 100/3.5 55 48 25 : 75 12 Pd(OAc)2 (2.5) Ag2O (2.0) AcOH DMF/DMSO (95 : 5) 100/3.5 66 62 28 : 72 13 Pd(OAc)2 (2.5) Ag2CO3 (2.0) EtCOOH DMF/DMSO (95 : 5) 100/3.5 80 71 35 : 65 14 Pd(OAc)2 (2.5) Ag2CO3 (2.0) PivOH DMF/DMSO (95 : 5) 100/3.5 45 45 22 : 78 15 Pd(OAc)2 (2.5) Ag2CO3 (2.0) AcOH DMF/DMSO (95 : 5) 80/3.5 43 40 17 : 83 16 Pd(OAc)2 (2.5) Ag2CO3 (2.0) AcOH DMF 100/3.5 75 70 34 : 66 17 Pd(OAc)2 (2.5) Ag2CO3 (2.0) AcOH DMA 100/3.5 81 75(68) 33 : 67 18 Pd(OAc) 2 (2.5) Ag 2 CO 3 (2.0) AcOH NMP 100/3.5 85 81(69) 36 : 64 19f Pd(OAc)2 (2.5) Ag2CO3 (2.0) AcOH NMP 100/3.5 82 66(51) 40 : 60 20g Pd(OAc)2 (2.5) Ag2CO3 (2.0) AcOH NMP 100/3.5 83 80 36 : 64